Floatz logo

URSODEOXYCHOLIC ACID

Adenomatous Polyposis Coli, Familial

Radboud University Medical CenterSmall moleculePhase 2/3Dormant
B
61/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
46/ 100
Competitive Position
95/ 100

Competitive context

11 Active assets in the Adenomatous Polyposis Coli, Familial cohort.

Asset / SponsorPhaseRating
Eflornithine
Cancer Prevention Pharmaceuticals, Inc.
Phase 3BB
Eicosapentanoic Acid
S.L.A. Pharma AG
Phase 3BB
Sulindac
Cancer Prevention Pharmaceuticals, Inc.
Phase 3BB
Azithromycin
Tel-Aviv Sourasky Medical Center
Phase 4BB
Erythromycin
michal roll
Phase 4BB

View all 27 →

Same molecule, other indications

URSODEOXYCHOLIC ACID is also rated in:

primary biliary cholangitisDormant
A
Indicative ·
82 / 100
View asset →
Nonalcoholic Steatohepatitis (NASH)Dormant
BBB
Indicative ·
74 / 100
View asset →
cirrhosis of liverDormant
BBB
Indicative ·
72 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →